Krishna Institute of Medical Sciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Krishna Institute of Medical Sciences Limited generated cash of $5,210,850,000, which is more than the previous year. Cash used in financing activities reached the amount of $2,167,550,000 last year. Net change in cash is therefore -$147,200,000.
Cash Flow
| 2016 | 603.67M | -408.17M | -302.86M |
|---|---|---|---|
| 2018 | 784M | -639.67M | -117.51M |
| 2020 | 2.01B | -1.24B | -443.38M |
| 2021 | 3.55B | -3.54B | 98.2M |
| 2023 | 4.32B | -6.15B | 883.4M |
| 2024 | 5.21B | -7.52B | 2.16B |
KIMS.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 616.11M | 256.34M | 405.14M | 80.63M | 84.15M | 139.65M |
Operating activities | ||||||
Net income | 3.10B | 4.84B | 2.79B | 1.40B | -473.55M | 266.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.46B | 1.29B | 695.36M | 706.1M | 400.68M | 354.98M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -402.91M | -628.1M | 177.46M | -132.06M | -264M | -309.21M |
Inventories | -65.79M | 64.7M | 62.92M | -30.48M | -37.33M | -10.55M |
Accounts payable | 499.42M | -410.83M | 239.2M | 134.34M | 243.11M | 0 |
Cash generated by operating activities | 5.21B | 4.32B | 3.55B | 2.01B | 784M | 603.67M |
Investing activities | ||||||
Purchases Of Investments | -2.92B | -5.39B | -2.40B | -170.36M | -4.2M | -33.13M |
Investments In Property Plant And Equipment | -6.47B | -5.74B | -944.26M | -519.8M | -585.13M | -348.36M |
Acquisitions Net | -741.08M | -2.16B | -352.73M | -727.44M | -63.61M | -26.68M |
Cash generated by investing activities | -7.52B | -6.15B | -3.54B | -1.24B | -639.67M | -408.17M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 950.23M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 5.13B | 1.48B | -1.41B | -23.09M | -93.28M | -285.73M |
Cash used in financing activities | 2.16B | 883.4M | 98.2M | -443.38M | -117.51M | -302.86M |
Net Change In Cash | -147.2M | 359.77M | 116.15M | 324.51M | 25.47M | -71.16M |
Cash at end of period | 468.91M | 616.11M | 521.29M | 405.14M | 109.62M | 68.49M |
| Data source | Data source | Data source | Data source | Data source | Data source |